Evidence map›Paper›PMID 29808370›Full record

ArticleNeurotoxicity research2018

The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Marissa Giovanna Schamne, Josiel Mileno Mack, Morgana Moretti, Filipe Carvalho Matheus, Roger Walz, Laurence Lanfumey, Rui Daniel Prediger

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Brain sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marissa Giovanna SchamneDepartment of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, 84049-900, Brazil.
Josiel Mileno MackDepartment of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, 84049-900, Brazil.
Morgana MorettiDepartment of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, 84049-900, Brazil.
Filipe Carvalho MatheusDepartment of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, 84049-900, Brazil.
Roger WalzDepartment of Clinical Medical, Center of Health Sciences, University Hospital, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, 84049-900, Brazil.
Laurence LanfumeyINSERM UMR S894, Centre de Psychiatrie et Neurosciences, 75014, Paris, France.
Rui Daniel PredigerDepartment of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, 84049-900, Brazil. rui.prediger@ufsc.br.
Universidade Federal de Santa Catarina · BRInserm · FR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico Universal 408676/2016-7Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção none
6 · The paper itself

Abstract

Depression is a highly prevalent and debilitating non-motor symptom observed during the early stages of Parkinson's disease (PD). Although PD prevalence is higher in men, the depressive symptoms in PD are more common in women. Therefore, the aim of this study was to investigate the development of anhedonic- and depressive-like behaviors in male and female mice and the potential mechanisms related to depressive symptoms in an experimental model of PD. Young adult male and female C57BL/6 mice (3 months old) received a single intranasal (i.n.) administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and were submitted to a battery of behavioral tasks (sucrose consumption, splash test, tail suspension, forced swimming and open field tests) to assess their emotional and motor profiles. Considering the role of sexual hormones in emotional behaviors, the same protocol of i.n. MPTP administration and the splash, tail suspension, and open field tests were conducted in ovariectomized (OVX) and aged C57BL/6 female (20 months old) mice. We also investigated the immunocontent of neurotrophins (BDNF, GDNF, and VEGF) in the hippocampus and prefrontal cortex by western blot. I.n.  MPTP administration induced more pronounced anhedonic- and selective depressive-like behaviors in female adult mice, also observed in OVX and aged female mice, with the absence of motor impairments. Furthermore, MPTP induced a more pronounced depletion of neurotrophins in the prefrontal cortex and hippocampus in female than male mice. This study provides new evidence of increased susceptibility of female mice to anhedonic- and depressive-like behaviors following i.n. MPTP administration. The observed gender-related effects of MPTP on emotional parameters seem to be linked to increased depletion of neurotrophins (particularly BDNF and GDNF) in the hippocampus and prefrontal cortex of female mice.

Indexed as

Administration, IntranasalAgingAnhedoniaAnimalsBrain-Derived Neurotrophic FactorDepressionFemaleGlial Cell Line-Derived Neurotrophic FactorHippocampusMaleMice, Inbred C57BLMotor ActivityMPTP PoisoningOvariectomyPrefrontal CortexSex FactorsBrain-Derived Neurotrophic FactorGdnf protein, mouseGlial Cell Line-Derived Neurotrophic FactorTyrosine 3-MonooxygenaseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseBDNFDepressionGDNFGender differencesIntranasal MPTPNeurotrophinsParkinson’s disease

Identifiers

PMID29808370
OpenAlexW2806361927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.